詳細(xì)說明
Address: Sindalsvej 30 8240 Risskov Danmark
Email: Info@lolina.dk
Product Specification
Product name | Lolina? Human UC-MSC heal-Exo? enhancer kit 2, Xeno Free, Exo Plus |
Cat.No. | NaC20120705 |
Storage and shipping | NaC20120705-A: 2-8 ℃ NaC20120705-B/C: Store at -20 ℃. Once added to medium, store at 4℃, do not refreeze after thawing. Dry ice transportation. Since the kit contains light-sensitive ingredients, please store it away from light. |
Product Description
Lolina? Human UC-MSC heal-Exo? enhancer kit 2 is a set of sterile powders or concentrated solution which contains growth factors, hormones, or proteins for directed induction of paracrine secretion and exosome protection.
As an treatments additive for UC-MSC in vitro culture, this supplement has been proved has following functions:
1. Strongly active the paracrine secretion of anti-inflammatory exosomes.
2. Exos produced under this condition showed excellent ability to promote wound regeneration by promoting angiogenesis without affecting liver and kidney function.
3. At the same time, ATV-Exos promoted the proliferation, migration, tube formation and VEGF levels of endothelial cells in vitro.Enhance the stability of MSCs.
4. The robustness of exosomes can be increased by enhancing the robustness of the exosome membrane.
5. Enhance the stress response pathway within MSCs to improve the robustness of exosomes.
Components
Compound No. | Compounds | Format | Size |
NaC20120705-A | StemExo? Antioxidant reagent | Liquid | 2ml |
NaC20120705-B | Atorvastatin (ATV) | Crystal solid | 2.888 μg |
NaC20120705-C | r-Human serum albumi (rHSA) | Lyophilized | 62.5 mg |
Instructions for Use
1. Stock solution Preparation.
One kit is for 50ml cell culture medium.
a. NaC20120705-A is a ready-to-use reagent, just and it into treatment medium to obtain desire concentration.
b. NaC20120705-B/C are offered as powder, their stock solutions are prepared as follows:
The compounds are offered as powder in tubes. Please centrifuge before opening the cap to ensure the accuracy of the dosage.
Please carry out dissolution and packaging operations on a clean bench.
Spray the medium bottle and supplement tube with 70% ethanol and wipe to remove excess liquid. In a sterile field, remove the caps without touching the interior threads with fingers.
Reconstitute NaC20120705-B in 10 μl sterile DMSO/enthonal. Aliquot into appropriate volumes of storage solution. Aliquot into appropriate volumes of storage solution. When stored at -20℃, the stock solution is stable for 4 years. When stored at 4 ℃, the stock solution is stable for 1 week.
Reconstitute NaC20120705-C in sterile 0.9% NaCl solution/base culture medium. The recommend volume is 5 mL. Aliquot into appropriate volumes of storage solution. When stored at 2-8 ℃, -20℃, the stock solution is stable for 24 month.
2. Protocol
Step 1: UC-MSC Culture
Seeding: Seed UC-MSC in culture flasks or plates at a density allowing them to reach 70-80% confluence.
Growth: Allow UC-MSC to grow until they reach the desired confluence.
Step 2: Pre-treatment with NaC20120705-A
Prepare pre-Treatment Medium:
a. Add the stock solution of NaC20120705-A to the culture medium to a final concentration. The dilution ratio range is from 0.3:50 to 1.13:50.
[Notes]: Please determine the optimal treatment concentration by setting up preliminary experiments to avoid cell damage caused by excessively high concentrations, which may lead to cell detachment and death.
Pre-treat UC-MSCs:
b. Replace the medium by the pre-treatidng medium. Treating cells for 2h under standard culture conditions (37 ℃, 5% CO2).
Step 3: Treatment UC-MSC with NaC20120305-B/C
Prepare Treatment Medium:
c. Thaw the stock solution.
d. Add the stock solution of NaC20120305-B/C to the regular culture medium to obtain a treatment medium. The dilution ratio is: NaC20120305-B 1:5000; NaC20120305-C 1:10.
Treat UC-MSCs:
e. Replace the regular culture medium with the treatment medium.
f. Incubate the UC-MSCs with the treatment medium for 24 hours under standard culture conditions (37 ℃, 5% CO2).
Step 3: Post-Treatment Handling
g. Remove Treatment Medium: After 24 hours of treatment, remove the treatment medium.
h. Wash MSCs: Wash the cells gently with PBS to remove any residual the treatment medium.
Conditioning Phase:
i. Replace with fresh, serum-free, or exosome-depleted medium.
j. Incubate the UC-MSCs for an additional 24-48 hours to collect the conditioned medium containing exosomes.
Step 4: Exosome Isolation and Purification
k. Collect the conditioned medium after the post-treatment incubation period.
Note
If handled improperly, some components of the medium may present a health hazard. Take appropriate precautions when handling it, including the wearing of protective clothing and eyewear. Dispose of properly.
產(chǎn)品詳細(xì)信息請聯(lián)系產(chǎn)品工程師